ABSTRACT
Introduction
It has been known for many years that estrogens administration to experimental animals during the neonatal period or adulthood can impair sperm production and maturation. Estrogens (E) are involved in the initiation and maintenance of testicular function and spermatogenesis and their action is important at numerous levels in male reproductive physiology, including, but not limited to, effects on the hypothalamo-pituitary-testis axis, Lydig cells (LC), Sertoli cells (SC), germ cells (GC) and epididimal function (4) . This axis regulates spermatogenesis by controlling the circulating levels of LH and FSH trough the feedback regulation of steroid hormones and this feedback loop can be intercepted by endocrine disruptors binding to estrogen receptors in the pituitary (7) . In the context of evaluating human risk from exposure to environmental estrogens an important question is what level of E-exposure will induce adverse changes to spermatogenesis and what end points most clearly reflect inappropriate E exposure? In earlier studies the negative effects of E were explained only as a result of suppression of gonadotropin secretion during the treatment. We previously demonstrated that neonatal treatment with E dose dependently affected pubertal spermatogenesis involving elevation of germ cell apoptosis, reduction of SC and total GC number and these changes persist trough the adulthood (2, 3). Our comparative studies on the effect of neonatal treatment with diethilstilboestrol (DES) or GnRH-antagonist (GnRHa) suggested direct and permanent effect of E on the testis mediated via ER-β localized in GC and SC (8) (2) and SC support to total germ cell (TGC) population.
In the literature there were no data about diethilstilboestrol (DES) effect on particular steps of GC differentiation during pubertal development. However, our recent studies on the onset of rat puberty (day 18) revealed different sensitivity of GC types toward neonatal E treatment. Spermatocytes (Sc) are more affected than spermatogonia (Sg) and among these types the more differentiated subtypes are more vulnerable (5, 6) . In this respect the current study continues our previous work by focusing on the action of E applied neonatally on spermatogenesis during late puberty (d 35). We aimed to assess GC development (different GC types) in tandem with SC support toward GC (efficiency of spermatogenesis) by complex systems of quantitative criteria. Comparative evaluation of GC types would elucidate the mechanisms of E action on the different stages of GC differentiation and the process of spermatogenesis. We also compared current data with our previous results for day 18 in order to assess if any differences emerge between the onset and expansion of spermatogenesis; if any reparative mechanisms switch on to compensate negative effects of hormonal disbalance with progressing of age?
Materials and Methods
We used experimental model for manipulation of neonatal hormonal environment by treatment with DES-10 µg, DES-1 µg or DES-0.1 µg in 20l corn oil on days 2, 4, 6, 8, 10 and 12; GnRH antagonist -10mg/kg in 20l 5% mannitol on days 2 and 5; 20l corn oil (vehicle) as control. Rats from all treatment groups were subsequently sampled on day 35. In situ detection of germ cell apoptosis by TUNEL method (9) and subsequent 121-point counting using cross-face sampling of 32 fields (3872 points) (3) were applied. We estimated absolute nuclear volume (ANV) of SC, total GC (TGC), spermatogonia (A-Sg, intermediate and B-Sg), spermatocytes including preleptotene (Pl), leptotene and zygotene (L+Z) and pachitene (Ph) spermatocytes, as well as spermatides (round -r. Sd and elongated spermatides -el. Sd) and the ratios of GC/ SC. Comparison of the different parameters of the various treatment groups was made using Student's ttest.
Results and Discussion
Gross morphology of the testis was assessed by testis weight (TW), proceedings of spermatogenesis, lumen formation, diameter of semen tubules, number of apoptotic cells. Comparative analysis on day 35 (late puberty) between different doses of DES as well as DES-10 and GnRHa clearly indicated dose dependent E action and differential effect of DES-10 and GnRHa. DES-10 greatly affected testis development and spermatogenesis whereas GnRHa was quite less effective in producing negative impact (Fig. 1) . We established clear correlations between extent of reduction of TW and the degree of suppression of spermatogenesis that characterize TW as a reliable macroparameter for assessment of GC development. Smaller testis indicates decrease in the number of testicular cells accompanied by increased cell death (7). Our previous data on day 18 demonstrated similar suppressive effects of DES-10 and GnRHa. Different pattern of E and GnRHa treatment during pubertal period (d 18-35) clearly suggest direct mechanism of action of DES on spermatogenic development mediated by estrogen receptor-β (ER-β) localized in GC and SC (8) . The hormonal profiles were also different in both treatment groups that support this suggestion (9) . Plasma FSH levels were markedly reduced at 18 and 25 day but not at 35 in GnRHa treated rats whereas in DES-treated animals FSH levels remained suppressed at day 35.
In late rat puberty (day 35) spermatogenesis proceeds upto spermatid (postmeiotic) stage of GC differentiation. Early and late stages can be distinguished by presence of round spermatides ( r. Sd step 1-8 of spermiogenesis) in early stages (I-VIII) of the spermatogenic cycle whereas late stages were identified by associations of early and late spermatocytes (Sc) and elongated spermatides (el. Sd later than step 9) if present.
In more advanced control el. Sd appeared upto step 12 of spermiogenesis (stage XII of the cycle) (Fig. 1a) . On day 35 TGC number decreased 13 times in DES-10, 4 times in GnRHa, 2 times in DES-1 and DES-0.1 (Fig. 2a) .
The ratio TGC/ Sertoli cells indicator for efficiency of spermatogenesis and supporting capacity of SC toward spermatogenesis was also greatly suppressed to the similar extent by DES-10 (13 times), less reduced by GnRHa (1.6 times) and not affected by lower doses DES (Fig. 3a) . Our previous data on day 18 revealed similar negative effects of DES-10 and GnRHa on TGC (by 4 times) and TGC/ Sertoli (less then 2 fold). Lower doses DES produced milder effect. Developmental comparison of our current (d 35) and previous data (d 18) suggest exacerbation of negative action of high E levels on the total germ cell population and efficiency of spermatogenesis during puberty. ES (less than 2 times) (Fig. 2a) . To establish whether the differentiating GC are important target for E action we quantified particular GC types in all the stages of the cycle. Enumeration of spermatogonial population (Sg) on day 35 showed stronger reduction in DES-10 (6 fold) than GnRHa (3 fold) and lesser effect by lower doses D. Similar tendency was found for total Sg/ SC in DES-10 group although GnRHa was less effective. Interesting positive effect emerged in lower doses (Fig. 3a) . Compared to data on day 18 GnRHa and DES-10 exerted similar negative effect on Sg (3 fold reduction) and lack of effect on Sg/ SC by DES-0.1.
Our data indicated deterioration of suppressed Sg development in the course of puberty after neonatal E exposure. The reduced number of mitotic dividing Sg in early puberty leads to their diminishing in late puberty. Sg are one of the populations that is target of direct E action (8) . In late puberty A-Sg were more sensitive to high dose DES (10 fold suppression) than In and B-Sg (4 fold). In contrast GnRHa produced relatively similar effect on both groups of Sg. Lower doses DES reduced this parameter less then twice (Fig. 2b) . Like for total Sg population, DES-10 produced same effect on supporting capacity of SC toward different types Sg; GnRHa failed to produce significant effect and lower doses were positive (Fig. 3B ). Comparing to day 18 the more differentiated Sg In+B were more vulnerable (more than 4 times) than A-Sg (1.5 times) by both treatments GnRHa and DES. In addition to direct action of E on Sg population we assume time dependent sensitivity of particular types of Sg, e. g. more advanced types are more vulnerable at onset of puberty compared to late puberty.
In relation to number of total spermatocytes (Sc-ANV) on day 35 we found out that high dose of DES greatly suppressed this parameter almost 12 times while GnRHa decreased this parameter by 3 times and lower doses of DES lesser than twice ( Fig. 2A) . Similar findings was established for Sc/ SC ratio in DES-10 and GnRHa treated animals while DES-1 and DES-0.1 administrations had a beneficial effect on efficiency of spermatogenesis (Fig. 3a) .
Comparing with early puberty (d 18) DES-10 induced the most markedly changes on total Sc number (10 fold) and GnRHa caused 6 fold decrease, lower doses exerted reduction similar to the late puberty. Probably restoration of gonadotropin levels brings about lesser reduction of Sc ANV in late puberty whereas high E values maintain the adverse negative impact on meiotic stages of spermatogenesis during entire investigated period (d 18-35).In GnRHa group supporting capacity of SC toward Sc on day 18 is comparable with that of late puberty but DES-10 produced stronger negative effect on day 35 -11 fold reduction than day 18 (4 fold). When we compared ANV of Sg with that of Sc on day 35 we ascertain that more differentiated meiotic stages of spermatogenesis (Sc) were more susceptible to E than mitotic GC types (Sg). Germ cell differentiation evaluated by Sc/ Sg ratio was more retardet in DES than GnRHa, as well. Among the Sc, the most differentiated subtype-pachytene Sc (Ph) was the most sensitive to hormonal disbalance and the effect of DES-10 was significantly more severe (17 times) than those of GnRHa (4 times). This tendency is observed also in the population of leptotene and zigotene (L+Z) spermatocites (respectively 10 and 2 fold) but not in the group of preleptotene Sc (pL) -DES-10 and GnRHa caused similar reduction of their number (3 fold) (Fig. 2c) .
Even GC meiosis occurred beyond blood-testis barrier (established by SC) the Sc are target for direct E action as they posses ER-β in addition to indirect action via SC (10) . Regarding SC support toward Sc subtypes we examined similar negative trend in DES animals. Lack of effect was found in GnRHa group and weak positive action was emerged in DES-0.1 (Fig. 3c) On day 35 r. Sd were present in control and in some cases el. Sd appeared in the seminal tubules (Fig. 1a) . High dose of DES induced arrest of spermatogenesis with lack of postmeiotic stages (spermatides) so resemble morphology of day 25 (spermatogenesis proceeds upto Sc stage) (Fig. 1c, Fig. 2d) . In GnRHa some r. Sd can be seen but severe reduction was found in their number (Fig. 2d) . In lower doses the parameter decreased respectively 4.5 and 3 times for DES-1 and 0.1 (Fig. 2b) . Our finding that r. Sd are the most vulnerable GC type is confirmed by Radhica N. and al (7) indicating that haploid spermatid population was primary affected after treatment with DES. Spermatides, the most differentiated GC population were the most sensitive to hormonal manipulation compared to Sg and Sc.
Conclusions
In conclusion our data indicate differential sensitivity of particular steps of spermatogenesis to hormonal disbalance induced by DES or GnRHa. Different mechanisms are probably involved in mediation of the effect of E and gonadotropins and direct E action on GC differentiation is suggested. Our finding would elucidate our understanding about the hormonal regulation of different germ cell steps of spermatogenesis.
